MAN1C1 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Kifunensine acts as a selective inhibitor of the MAN1C1 enzyme, exhibiting distinctive molecular interactions that disrupt the hydrolysis of mannose-rich oligosaccharides. Its unique stereochemistry facilitates strong binding to the enzyme's active site, leading to altered reaction kinetics. This compound's interference with glycan remodeling processes highlights its role in modulating glycoprotein maturation and influencing cellular glycan profiles, thereby impacting various biological pathways. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine is an inhibitor of Golgi alpha-mannosidase II, which is involved in glycoprotein processing, similar to MAN1C1. By inhibiting this process, Swainsonine could disrupt the glycosylation process that MAN1C1 is part of, leading to its functional inhibition. | ||||||
Deoxymannojirimycin hydrochloride | 84444-90-6 | sc-201360 sc-201360A | 1 mg 5 mg | $93.00 $239.00 | 2 | |
Deoxymannojirimycin, a mannosidase inhibitor, can interfere with the glycosylation process involving MAN1C1, potentially inhibiting its function in the processing of N-linked glycans. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine, an inhibitor of beta-glucosidase, could indirectly inhibit MAN1C1 by affecting glycoprotein processing pathways where MAN1C1 plays a role, particularly in the modification of N-linked glycans. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
1-Deoxynojirimycin, another alpha-mannosidase inhibitor, could disrupt the functional activity of MAN1C1 by inhibiting the processing of N-linked glycans, a process where MAN1C1 is involved. | ||||||
Voglibose | 83480-29-9 | sc-204384 sc-204384A | 10 mg 50 mg | $198.00 $681.00 | ||
Voglibose, an alpha-glucosidase inhibitor, could inhibit MAN1C1 by impacting glycoprotein processing pathways, particularly those involving the maturation of N-linked glycans. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
Acarbose, another alpha-glucosidase inhibitor, might inhibit MAN1C1 by affecting glycoprotein processing and N-linked glycan modification, processes in which MAN1C1 is involved. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Pyrrolidine dithiocarbamate, a NF-kB inhibitor, may indirectly inhibit MAN1C1 by affecting signaling pathways that influence glycoprotein processing, a process where MAN1C1 plays a role. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A, an inhibitor of protein transport from the endoplasmic reticulum to the Golgi apparatus, could inhibit MAN1C1 by disrupting the glycoprotein processing pathway in which it is involved. | ||||||